Surging Demand For Biopharmaceuticals Fuels Growth Of Single-Use Bioprocessing Market: The Driving Engine Behind Single Use Bioprocessing Market Evolution in 2025

Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Single Use Bioprocessing Market Size Growth Forecast: What to Expect by 2025?
The market encompassing single-use bioprocessing technologies has experienced substantial recent expansion, projected to elevate its valuation from $26.87 billion in 2024 to $31.94 billion by 2025, reflecting an annual growth rate averaging 18.9 percent. Historic market advancement stemmed from several key factors, including the expansion of biopharmaceutical manufacturing, advancements in biotechnology and cell culture techniques, the imperative to minimize the potential for cross-contamination, adherence to stringent bioprocessing regulations, and the increasing requirement for economically advantageous solutions.

How Will the Single Use Bioprocessing Market Size Evolve and Grow by 2029?
The market centered around disposable bioprocessing equipment anticipates a period of rapid and substantial expansion in the upcoming years, projected to reach a valuation of $68.04 billion by 2029, driven by a compound annual growth rate (CAGR) of 20.8%. This projected upswing throughout the forecast timeframe is fueled by several factors, including the proliferation of personalized medicine approaches, the increasing production of gene and cell therapies, the wider integration of continuous bioprocessing techniques, the development of biomanufacturing capabilities for addressing rare diseases, enhancements in biosafety containment levels, and the emergence of new markets alongside globally recognized biomanufacturing centers. Key developments expected to shape this market during the forecast include the integration of automated and robotic solutions within single-use platforms, the advancement of sensor technology and analytical tools for disposable systems, the adoption of closed-system methods for aseptic filling and final packaging, the construction of adaptable and scalable bioprocessing sites, the development of capabilities for manufacturing products both on-demand and at decentralized locations, and ongoing innovation in virus separation and purification technologies.

View the full report here:
https://www.thebusinessresearchcompany.com/report/single-use-bioprocessing-global-market-report

What Drivers Are Propelling the Growth of Single Use Bioprocessing Market Forward?
Anticipation is high that the escalating need for biopharmaceuticals, which are therapeutic agents derived from living cells or organisms, will fuel the expansion of the single-use bioprocessing sector moving ahead. These single-use systems are widely adopted within biopharmaceutical production workflows because they enhance output, reduce expenses, and facilitate secure waste management. To illustrate this sector's strength, the European pharmaceutical output registered considerable advancement between 2021 and 2022, climbing from $352.48 billion to $369.95 billion, as reported by EFPIA, the European Federation of Pharmaceutical Industries and Associations based in Belgium, in June 2023; consequently, this rising requirement for biopharmaceuticals serves as the primary impetus behind the expansion of the single-use bioprocessing market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7700&type=smp

Which Emerging Trends Are Transforming the Single Use Bioprocessing Market in 2025?
A noteworthy trend flourishing within the sphere of single-use bioprocessing involves significant technological leaps, compelling key industry players to incorporate computational capabilities to secure their market standing. As an illustration of this innovation wave, Cytiva, a firm originating from the United States, launched its X-platform bioreactors in April 2023; these systems were specifically designed to bolster upstream single-use bioprocessing effectiveness and, starting at capacities of 50 up to 200 liters, they integrate the Figurate automation software package, all with the objective of optimizing process throughput via greater output volumes, superior user convenience, and more streamlined logistical chains.

What Are the Key Segments in the Single Use Bioprocessing Market?
The single use bioprocessingmarket covered in this report is segmented -

1) By Product: Single-Use Media Bags And Containers; Single-Use Assemblies; Single-Use Bioreactors; Disposable Mixers; Other Products
2) By Workflow: Upstream; Fermentation; Downstream
3) By Application: Filtration; Storage; Cell Culture; Mixing; Purification
4) By End User: Biopharmaceutical And Pharmaceutical companies; Contract Research Organizations And Contract Manufacturing Organizations (CROs and CMOs); Academic and Research institutes

Subsegments:
1) By Single-Use Media Bags and Containers: Media Bags; Storage Containers; Transport Bags
2) By Single-Use Assemblies: Preassembled Kits; Tubing Sets; Connector Assemblies
3) By Single-Use Bioreactors: Stirred-Tank Bioreactors; Wave-Mixed Bioreactors; Other Bioreactor Types
4) By Disposable Mixers: Single-Use Stirring Devices; Single-Use Agitators
5) By Other Products: Filtration Devices; Sampling Devices; Accessories

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=7700&type=smp

Who Are the Key Players Shaping the Single Use Bioprocessing Market's Competitive Landscape?
Major companies operating in the single use bioprocessing market include GE Healthcare Technologies Ltd., Eppendorf AG, Corning Incorporated, Thermo Fisher Scientific Inc., Sartorius AG, JM BioConnect BV, Merck KGaA, Pall Corporation, Kuhner AG, PBS Biotech Inc., Entegris Inc., DistriCell Inc., ABEC Inc., Able Corporation and Biott Corporation, Solida Biotech GmbH, OmniBRx Biotechnologies Pvt. Ltd., Satake Chemical Equipment Mfg. Co. Ltd., Stobbe Pharma GmbH, Celltainer Biotech BV, Cellexus BV, Danaher Corporation, Boehringer Ingelheim International GmbH, General Electric Company, Rentschler Biopharma SE, Repligen Corporation, Sollesis Medical Plc, Charter Medical Inc., Secant Group LLC, Lonza Group Ltd., Hoffmann-La Roche Ltd., Novartis AG, Teva Pharmaceutical Industries Ltd., Sanofi S.A., Pfizer Inc., Catalent Inc., Patheon Inc., Bio-Rad Laboratories Inc., Avantor Performance Materials India Limited, MilliporeSigma, Saint-Gobain Performance Plastics Corp., Meissner Filtration Products Inc.

What Geographic Markets Are Powering Growth in the Single Use Bioprocessing Market?
North America was the largest region in the single-use bioprocessing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the single use bioprocessing market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7700

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.